Review




Structured Review

Applied Proteomics Inc reverse phase protein microarray
Summary of molecular findings in the Side Out 2 trial based on patients’ GMIs. Frequencies of gene expression, protein expression by immunohistochemistry and protein activation by <t>RPPA</t> (Panel A, Panel B, and Panel C, respectively) for 22 of the 25 patients enrolled in the Side Out 2 trial.
Reverse Phase Protein Microarray, supplied by Applied Proteomics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rppa+microarrayer/reverse+phase+protein+microarray/pmc08732340-69-35-10
Average 90 stars, based on 1 article reviews
reverse phase protein microarray - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial"

Article Title: Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

Journal: Molecular Oncology

doi: 10.1002/1878-0261.13091

Summary of molecular findings in the Side Out 2 trial based on patients’ GMIs. Frequencies of gene expression, protein expression by immunohistochemistry and protein activation by RPPA (Panel A, Panel B, and Panel C, respectively) for 22 of the 25 patients enrolled in the Side Out 2 trial.
Figure Legend Snippet: Summary of molecular findings in the Side Out 2 trial based on patients’ GMIs. Frequencies of gene expression, protein expression by immunohistochemistry and protein activation by RPPA (Panel A, Panel B, and Panel C, respectively) for 22 of the 25 patients enrolled in the Side Out 2 trial.

Techniques Used: Gene Expression, Expressing, Immunohistochemistry, Activation Assay

Related Articles

Activation Assay:

Article Title: Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial
Article Snippet: .. Patient‐matched fresh frozen material was used by the Center for Applied Proteomics and Molecular Medicine at George Mason University for protein pathway activation mapping using laser capture microdissection (LCM) to isolate tumor epithelia followed by Reverse Phase Protein Microarray (RPPA) analysis as previously described [ ]. .. The LCM‐RPPA assay, although not cleared nor approved by the FDA, has been developed and evaluated in accordance with the College of American Pathologist guidelines.

Laser Capture Microdissection:

Article Title: Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial
Article Snippet: .. Patient‐matched fresh frozen material was used by the Center for Applied Proteomics and Molecular Medicine at George Mason University for protein pathway activation mapping using laser capture microdissection (LCM) to isolate tumor epithelia followed by Reverse Phase Protein Microarray (RPPA) analysis as previously described [ ]. .. The LCM‐RPPA assay, although not cleared nor approved by the FDA, has been developed and evaluated in accordance with the College of American Pathologist guidelines.

Microarray:

Article Title: Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial
Article Snippet: .. Patient‐matched fresh frozen material was used by the Center for Applied Proteomics and Molecular Medicine at George Mason University for protein pathway activation mapping using laser capture microdissection (LCM) to isolate tumor epithelia followed by Reverse Phase Protein Microarray (RPPA) analysis as previously described [ ]. .. The LCM‐RPPA assay, although not cleared nor approved by the FDA, has been developed and evaluated in accordance with the College of American Pathologist guidelines.



Similar Products

90
Aushon Biosystems rppa microarrayer
Rppa Microarrayer, supplied by Aushon Biosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rppa+microarrayer/rppa+microarrayer/pm28536445-205-6-8
Average 90 stars, based on 1 article reviews
rppa microarrayer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results